Vanda, Megapharm in deal for schizophrenia drug Fanapt in Israel
This article was originally published in Scrip
Executive Summary
Vanda Pharmaceuticals, the Rockville, Maryland-based developer of drugs for CNS disorders, has entered into an exclusive licence agreement with the Israeli-based company Megapharm for the commercialisation of the twice-daily, oral atypical antipsychotic Fanapt (iloperidone) in Israel.